220 results on '"Yujiri, Toshiaki"'
Search Results
2. Differential diagnosis of infectious diseases, drug-induced lung injury, and pulmonary infiltration due to underlying malignancy in patients with hematological malignancy using HRCT
3. Significance of alveolar nitric oxide concentration in the airway of patients with organizing pneumonia after allogeneic hematopoietic stem cell transplantation
4. High-resolution CT findings of pulmonary infections in patients with hematologic malignancy: comparison between patients with or without hematopoietic stem cell transplantation
5. Early dynamics of chronic myeloid leukemia on nilotinib predicts deep molecular response
6. Differentiation of pulmonary complications with extensive ground-glass attenuation on high-resolution CT in immunocompromised patients
7. TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients
8. Differential diagnosis of pulmonary infections in immunocompromised patients using high-resolution computed tomography
9. Efficacy and Long-Term Outcomes of Autologous Stem Cell Transplantation in POEMS Syndrome: A Nationwide Survey in Japan
10. Bortezomib-based strategy with autologous stem cell transplantation for newly diagnosed multiple myeloma: a phase II study by the Japan Study Group for Cell Therapy and Transplantation (JSCT-MM12)
11. MEKK1 Is Essential for Cardiac Hypertrophy and Dysfunction Induced by Gq
12. MEK Kinase 1 Gene Disruption Alters Cell Migration and c-Jun NH 2 -Terminal Kinase Regulation but Does Not Cause a Measurable Defect in NF-κ B Activation
13. MEKK1 Suppresses Oxidative Stress-Induced Apoptosis of Embryonic Stem Cell-Derived Cardiac Myocytes
14. A Case of Pulmonary Langerhans Cell Histiocytosis With Acute Progressive Nodular Lesions Depicted on High-Resolution Computed Tomography
15. Role of MEKK1 in Cell Survival and Activation of JNK and ERK Pathways Defined by Targeted Gene Disruption
16. Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALL
17. Impacts of graft-versus-host disease on outcomes after allogeneic hematopoietic stem cell transplantation for chronic myelomonocytic leukemia: A nationwide retrospective study
18. Diagnostic challenge of Diamond–Blackfan anemia in mothers and children by whole-exome sequencing
19. Soluble interleukin-2 receptor index predicts the development of acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation from unrelated donors
20. JAK2 46/1 haplotype is associated with JAK2 V617F-positive myeloproliferative neoplasms in Japanese patients
21. High-resolution computed tomography of chest complications in patients treated with hematopoietic stem cell transplantation
22. Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
23. Idiopathic pneumonia syndrome with thrombotic microangiopathy-related changes after allogeneic hematopoietic stem cell transplantation
24. Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
25. Recurrent extramedullary relapse of acute myelogenous leukemia after allogeneic hematopoietic stem cell transplantation in a patient with the chromosomal abnormality t(8;21) and CD56-positivity
26. Increased serum levels of matrix metalloproteinase-9 in acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation
27. SIRT1 is downregulated during peripheral blood stem cell mobilization in healthy donors by granulocyte-colony stimulating factor
28. MEK kinase 1 is essential for Bcr–Abl-induced STAT3 and self-renewal activity in embryonic stem cells
29. MEK kinase 1 mediates the antiapoptotic effect of the Bcr-Abl oncogene through NF-κB activation
30. A case–control study of bronchiolitis obliterans syndrome following allogeneic hematopoietic stem cell transplantation
31. Activation of the unfolded protein response in primary acute myeloid leukemia cells
32. Alteration in serum B cell-activating factor levels inpatients with idiopathic thrombocytopenic purpura after Helicobacter pylori eradication therapy
33. Hematopoietic Progenitor Cell Count, but Not Immature Platelet Fraction Value, Predicts Successful Harvest of Autologous Peripheral Blood Stem Cells
34. Increased serum levels of high-mobility group box 1 protein in patients who developed acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation
35. Anti-apoptotic versus pro-apoptotic signal transduction: Checkpoints and stop signs along the road to death
36. Alteration of Adipokines During Peripheral Blood Stem Cell Mobilization Induced by Granulocyte Colony-Stimulating Factor
37. Prospective monitoring of BCR-ABL1 transcript levels in patients with Philadelphia chromosome-positive acute lymphoblastic leukaemia undergoing imatinib-combined chemotherapy
38. Nephrotic syndrome associated with thrombotic microangiopathy following allogeneic stem-cell transplantation for myelodysplastic syndrome
39. Sustained Cytogenetic Remission Induced by Imatinib Mesylate in a Chronic Myeloid Leukemia Patient Who Had a Relapse into Lymphoid Crisis after Allogeneic Hematopoietic Stem Cell Transplantation
40. Elevation of serum high-mobility group box 1 protein during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilisation
41. Autografting followed by a reduced-intensity conditioning unrelated donor cord blood transplantation for a patient with refractory multiple myeloma: successful engraftment with minimal toxicity
42. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura
43. Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance
44. Reactivation of hepatitis B virus in a hepatitis B surface antigen-negative patient with acute promyelocytic leukemia treated with arsenic trioxide
45. Fluctuations in thrombopoietin, immature platelet fraction, and glycocalicin levels in a patient with cyclic thrombocytopenia
46. A Case of Hand-Mirror Cell Variant of Multiple Myeloma
47. Optimal treatment strategy with nilotinib for patients with newly diagnosed chronic‐phase chronic myeloid leukemia based on early achievement of deep molecular response (MR4.5): The phase 2, multicenter N‐Road study.
48. The Role of MEK Kinase 1 in Bcr-Abl-Induced Self-Renewal Activity of Embryonic Stem Cells
49. Transient Appearance of Plasmablasts in the Peripheral Blood of Japanese Patients With Severe Fever With Thrombocytopenia Syndrome.
50. Automatic Isolation of Bone Marrow Mononuclesr Cells Using Fenwal CS-3000 Plus Blood Cell Sparator
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.